Jeff Yass’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$309K Buy
243,163
+96,359
+66% +$157K ﹤0.01% 10885
2026
Q2
$273K Sell
146,804
-71,532
-33% -$139K ﹤0.01% 11263
2026
Q1
$487K Sell
218,336
-84,951
-28% -$233K ﹤0.01% 9740
2025
Q4
$1.05M Buy
303,287
+84,866
+39% +$255K ﹤0.01% 7073
2025
Q3
$452K Buy
218,421
+53,863
+33% +$135K ﹤0.01% 9191
2025
Q2
$357K Buy
164,558
+36,853
+29% +$72.7K ﹤0.01% 9951
2025
Q1
$192K Buy
127,705
+72,393
+131% +$222K ﹤0.01% 10978
2024
Q4
$278K Buy
55,312
+23,792
+75% +$172K ﹤0.01% 9998
2024
Q3
$254K Buy
+31,520
New +$295K ﹤0.01% 9970
2024
Q2
– Sell
-72,602
Closed -$588K – 11969
2024
Q1
$864K Buy
72,602
+56,830
+360% +$620K ﹤0.01% 7238
2023
Q4
$295K Buy
+15,772
New +$140K ﹤0.01% 9882
2023
Q2
– Sell
-13,800
Closed -$213K – 11996
2023
Q1
$213K Buy
+13,800
New +$223K ﹤0.01% 10467

Other funds holding ANVS

Jeff Yass's ANVS Position: Q3 2026 in Review

Jeff Yass increased its Annovis Bio (ANVS) stake by 66% in Q3 2026, buying an estimated $157K and bringing the position to 243,163 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #10885.

Jeff Yass first reported a position in ANVS in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.05M in Q4 2025. 60 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • Jeff Yass held 243,163 shares of Annovis Bio worth $309K as of Q3 2026.
  • Jeff Yass bought 96,359 Annovis Bio shares in Q3 2026, an estimated $157K.
  • Annovis Bio made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10885 holding.
  • Jeff Yass first reported a position in Annovis Bio in Q1 2023 and has held it in 12 quarters since.
  • Jeff Yass's Annovis Bio position peaked at $1.05M in Q4 2025.
  • 60 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.